380 related articles for article (PubMed ID: 32061002)
21. Contrast-enhanced ultrasound-guided biopsy of suspicious breast lesions on contrast-enhanced mammography and contrast-enhanced MRI: a case series.
Huang PY; Tsai MY; Huang JS; Lin PY; Chou CP
J Med Ultrason (2001); 2023 Oct; 50(4):521-529. PubMed ID: 37493921
[TBL] [Abstract][Full Text] [Related]
22. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
[TBL] [Abstract][Full Text] [Related]
23. Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging.
Wang L; Wang P; Shao H; Li J; Yang Q
Eur Radiol; 2024 May; 34(5):3342-3351. PubMed ID: 37853174
[TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study.
Cozzi A; Schiaffino S; Fanizza M; Magni V; Menicagli L; Monaco CG; Benedek A; Spinelli D; Di Leo G; Di Giulio G; Sardanelli F
Eur Radiol; 2022 Nov; 32(11):7388-7399. PubMed ID: 35648209
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense Breasts.
Moffa G; Galati F; Maroncelli R; Rizzo V; Cicciarelli F; Pasculli M; Pediconi F
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568883
[TBL] [Abstract][Full Text] [Related]
26. CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer.
Ancona A; Telegrafo M; Fella RR; Iamele D; Cantore S; Moschetta M
Eur Radiol Exp; 2024 Apr; 8(1):32. PubMed ID: 38556593
[TBL] [Abstract][Full Text] [Related]
27. Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings.
Bickelhaupt S; Tesdorff J; Laun FB; Kuder TA; Lederer W; Teiner S; Maier-Hein K; Daniel H; Stieber A; Delorme S; Schlemmer HP
Eur Radiol; 2017 Feb; 27(2):562-569. PubMed ID: 27193776
[TBL] [Abstract][Full Text] [Related]
28. Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
Gelardi F; Ragaini EM; Sollini M; Bernardi D; Chiti A
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010240
[TBL] [Abstract][Full Text] [Related]
29. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
30. Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis.
Kaiyin M; Lingling T; Leilei T; Wenjia L; Bin J
Breast Cancer Res Treat; 2023 Nov; 202(1):1-9. PubMed ID: 37615793
[TBL] [Abstract][Full Text] [Related]
31. Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis.
Fueger BJ; Clauser P; Kapetas P; Pötsch N; Helbich TH; Baltzer PAT
Breast; 2021 Apr; 56():53-60. PubMed ID: 33618160
[TBL] [Abstract][Full Text] [Related]
32. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
[TBL] [Abstract][Full Text] [Related]
33. Are contrast enhanced mammography and digital breast tomosynthesis equally effective in diagnosing patients recalled from breast cancer screening?
Siminiak N; Pasiuk-Czepczyńska A; Godlewska A; Wojtyś P; Olejnik M; Michalak J; Nowaczyk P; Gajdzis P; Godlewski D; Ruchała M; Czepczyński R
Front Oncol; 2022; 12():941312. PubMed ID: 36505843
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
Açar ÇR; Orguc S
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38777678
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
[TBL] [Abstract][Full Text] [Related]
36. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.
Shahraki Z; Ghaffari M; Nakhaie Moghadam M; Parooie F; Salarzaei M
Breast Dis; 2022; 41(1):303-315. PubMed ID: 35754256
[TBL] [Abstract][Full Text] [Related]
37. Enhancement Type at Contrast-enhanced Mammography and Association with Malignancy.
Kim G; Mehta TS; Brook A; Du LH; Legare K; Phillips J
Radiology; 2022 Nov; 305(2):299-306. PubMed ID: 35819328
[TBL] [Abstract][Full Text] [Related]
38. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.
Gilbert FJ; van den Bosch HC; Petrillo A; Siegmann K; Heverhagen JT; Panizza P; Gehl HB; Pediconi F; Diekmann F; Peng WJ; Ma L; Sardanelli F; Belli P; Corcione S; Zechmann CM; Faivre-Pierret M; Martincich L
J Magn Reson Imaging; 2014 May; 39(5):1272-86. PubMed ID: 25006633
[TBL] [Abstract][Full Text] [Related]
39. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
[TBL] [Abstract][Full Text] [Related]
40. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
Åhsberg K; Gardfjell A; Nimeus E; Rasmussen R; Behmer C; Zackrisson S; Ryden L
World J Surg Oncol; 2020 May; 18(1):100. PubMed ID: 32438917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
